معرفی
David Bryder is a Professor at Lund University, holding multiple leadership positions including Research Group Leader in the Department of Molecular Hematology, Principal Investigator for Developmental Hematopoiesis, Principal Investigator for StemTherapy: National Initiative on Stem Cells for Regenerative Therapy, and Principal Investigator for LUCC: Lund University Cancer Center. His work focuses on hematopoietic stem cells, aging, and leukemia development.
Dr. Bryder's research interests span several key areas in hematology and stem cell biology:
- Hematopoietic Stem Cell biology and function
- Cellular Aging and immunosenescence
- Leukemia development and progression
- Fetal vs. adult hematopoiesis
- Stem cell therapy for age-related blood disorders
His recent research output shows a strong focus on understanding how aging affects blood stem cells and the immune system, with particular emphasis on developing therapies to rejuvenate aged hematopoietic stem cells. His work bridges basic stem cell biology with clinical applications for blood disorders and leukemia.
Dr. Bryder has received funding from multiple prestigious organizations including:
- Cancerfonden for "Leukemia-Induced Alterations in the Bone Marrow Microenvironment" (2025-2028)
- The Childhood Cancer Foundation for "Tumor suppression during fetal development" (2023-2025)
- Swedish Research Council for "Aging of blood stem cells, immunosenescence and possibilities for rejuvenation" (2023-2028)
He actively supervises doctoral students and participates in academic activities, having organized seminars on hematopoietic stem cell transplantation and served on examination boards for PhD candidates. His research group is part of multiple collaborative networks focusing on stem cell biology and cancer research.
